NCT00068692 - Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer | Biotech Hunter

Enrollment

225

Participants

Timeline

Start Date

October 15, 2003

Primary Completion Date

November 15, 2016

Study Completion Date

November 15, 2016

Conditions

Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal CarcinomaStage IIA Rectal Cancer AJCC v7Stage IIB Rectal Cancer AJCC v7Stage IIC Rectal Cancer AJCC v7Stage IIIA Rectal Cancer AJCC v7Stage IIIB Rectal Cancer AJCC v7Stage IIIC Rectal Cancer AJCC v7Stage IVA Rectal Cancer AJCC v7Stage IVB Rectal Cancer AJCC v7

Interventions

RADIATION

Radiotherapy

Undergo external beam radiation therapy

DRUG

Fluorouracil

Given IV

DRUG

Leucovorin Calcium

Given IV

DRUG

Oxaliplatin

Given IV

DRUG

Irinotecan

Given IV

Trial Locations (1)

02215

Eastern Cooperative Oncology Group, Boston

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH